Showing results (231-240 of 305) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase InhibitionStephanie Lheureux, Jeff P Bruce, Julia V Burnier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 5, 2022
Interobserver and intraobserver variability of RECIST assessment in ovarian cancerMichael Krasovitsky, Yeh Chen Lee, Hao-Wen Sim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2012
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trialStéphanie Lheureux, Sophie Krieger, Béatrice Weber, et al.
Annals of Intensive Care|April 10, 2021
An international tool to measure perceived stressors in intensive care units: the PS-ICU scaleAlexandra Laurent, Alicia Fournier, Florent Lheureux, et al.
Journal of Nursing Care Quality|October 10, 2022
Management of Malignant Bowel Obstruction: An Innovative Proactive Outpatient Nurse-Led Model of Care for Patients With Advanced Gynecologic CancerNazlin Jivraj, Yeh Chen Lee, Lisa Tinker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2020
PARP Inhibitors in the Management of Ovarian Cancer: ASCO GuidelineWilliam P Tew, Christina Lacchetti, Annie Ellis, et al.
Molecular Oncology|April 17, 2016
Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracyNicolas Vigneron, Matthieu Meryet-Figuière, Audrey Guttin, et al.
Gynecologic Oncology|January 22, 2022
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysisA Poveda, S Lheureux, N Colombo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2023
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancersEduardo Gonzalez-Ochoa, Michael Milosevic, Bradley Corr, et al.
Pageof 31